EE40 Cost-Effectiveness of GLP-1 Receptor Agonists Versus Long-Acting Insulins in Type 2 Diabetes From the Healthcare Sector Perspective: A Model-Based Analysis Using Real-World Data
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.293
https://www.valueinhealthjournal.com/article/S1098-3015(22)02497-4/fulltext
Title :
EE40 Cost-Effectiveness of GLP-1 Receptor Agonists Versus Long-Acting Insulins in Type 2 Diabetes From the Healthcare Sector Perspective: A Model-Based Analysis Using Real-World Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02497-4&doi=10.1016/j.jval.2022.09.293
First page :
Section Title :
Open access? :
No
Section Order :
12100